Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures

In early stage non-small cell lung cancer (NSCLC) large randomized trials have demonstrated that in patients with radically resected disease adjuvant chemotherapy improves 5-year survival rates. However, a customization of systemic treatment is needed to avoid treatments in patients cured by surgery...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transl Lung Cancer Res
Autori principali: Carnio, Simona, Novello, Silvia, Papotti, Mauro, Loiacono, Marco, Scagliotti, Giorgio Vittorio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pioneer Bioscience Publishing Company 2013
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367732/
https://ncbi.nlm.nih.gov/pubmed/25806256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.10.05
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi